Next Article in Journal
The A2UFood Project—Avoidable and Unavoidable Food Wastes: A Holistic Managing Approach for Urban Environments
Previous Article in Journal
Application of SORTS, a Novel Gene-Edited Cell Selection Method for HIV Study and Therapy
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Abstract

Activation and Antagonism of the OAS–RNase L Pathway †

Department of Microbiology, Perelman School of Medicine. University of Pennsylvania, Philadelphia, PA 19104, USA
Presented at Viruses 2020—Novel Concepts in Virology, Barcelona, Spain, 5–7 February 2020.
Proceedings 2020, 50(1), 14; https://doi.org/10.3390/proceedings2020050014
Published: 4 June 2020
(This article belongs to the Proceedings of Viruses 2020—Novel Concepts in Virology)

Abstract

:
The oligoadenylate synthetase–ribonuclease L (OAS–RNase L) system is a potent antiviral pathway that severely limits the pathogenesis of many viruses. Upon sensing dsRNA, OASs produce 2′,5′-oligoadenylates (2-5A) that activate RNase L to cleave both host and viral single-stranded RNA, thereby limiting protein production, virus replication and spread, leading to apoptotic cell death. Endogenous host dsRNA, which accumulates in the absence of adenosine deaminase acting on RNA (ADAR)1, can also activate RNase L and lead to apoptotic cell death. RNase L activation and antiviral activity during infections with several types of viruses in human and bat cells is dependent on OAS3 but independent of virus-induced interferon (IFN) and, thus, RNase L can be activated even in the presence of IFN antagonists. Differently from other human viruses examined, Zika virus is resistant to the antiviral activity of RNase L and instead utilizes RNase L to enhance its replication factories to produce more infectious virus. Some betacoronaviruses antagonize RNase L activation by expressing 2′,5′-phosphodiesterases (PDEs) that cleave 2-5A and thereby antagonize activation of RNase L. The best characterized of these PDEs is the murine coronavirus (MHV) NS2 accessory protein. Enzymatically active NS2 is required for replication in myeloid cells and in the liver. Interestingly, while wild type mice clear MHV from the liver by 7–10 days post-infection, RNase L knockout mice fail to effectively clear MHV, probably due to diminished apoptotic death of infected cells. We suggest that RNase L antiviral activity stems from direct cleavage of viral genomes and cessation of protein synthesis as well as through promoting death of infected cells, limiting the spread of virus. Importantly, OASs are pattern recognition receptors and the OAS–RNase L pathway is a primary innate response pathway to viruses, capable of early response, coming into play before IFN is induced or when the virus shuts down IFN signaling.

Funding

The research is funded by NIH R01-AI1104887; R01-AI140442.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Weiss, S.R. Activation and Antagonism of the OAS–RNase L Pathway. Proceedings 2020, 50, 14. https://doi.org/10.3390/proceedings2020050014

AMA Style

Weiss SR. Activation and Antagonism of the OAS–RNase L Pathway. Proceedings. 2020; 50(1):14. https://doi.org/10.3390/proceedings2020050014

Chicago/Turabian Style

Weiss, Susan R. 2020. "Activation and Antagonism of the OAS–RNase L Pathway" Proceedings 50, no. 1: 14. https://doi.org/10.3390/proceedings2020050014

Article Metrics

Back to TopTop